ETF constituents for IBRN

Below, a list of constituents for IBRN (iShares Neuroscience and Healthcare ETF) is shown. In total, IBRN consists of 63 securities.

Note: The data shown here is as of date Feb 29, 2024 (the latest that can be sourced directly from the fund provider).

Click here to go back to the full list of ETFs.

Ticker Name Sector Asset Class Market Value Weight (%)
BHVN BIOHAVEN LTD Health Care Equity 189705.54 4.94
NBIX NEUROCRINE BIOSCIENCES INC Health Care Equity 172976.65 4.51
CERE CEREVEL THERAPEUTICS HOLDINGS INC Health Care Equity 170198.08 4.43
AXNX AXONICS INC Health Care Equity 167702.6 4.37
ARGX ARGENX SE ADR Health Care Equity 167009.21 4.35
SRPT SAREPTA THERAPEUTICS INC Health Care Equity 166824.63 4.35
BIIB BIOGEN INC Health Care Equity 161389.64 4.21
ITCI INTRA CELLULAR THERAPIES INC Health Care Equity 160774.32 4.19
IART INTEGRA LIFESCIENCES HOLDINGS CORP Health Care Equity 159521.4 4.16
PTCT PTC THERAPEUTICS INC Health Care Equity 151880.96 3.96
XENE XENON PHARMACEUTICALS INC Health Care Equity 151317.0 3.94
ALKS ALKERMES Health Care Equity 148539.75 3.87
326030 SK BIOPHARMACEUTICALS LTD Health Care Equity 141971.01 3.7
SUPN SUPERNUS PHARMACEUTICALS INC Health Care Equity 127469.72 3.32
ACAD ACADIA PHARMACEUTICALS INC Health Care Equity 124943.0 3.26
CPRX CATALYST PHARMACEUTICALS INC Health Care Equity 117388.05 3.06
NEU NEUREN PHARMACEUTICALS LTD Health Care Equity 109026.1 2.84
AVDL AVADEL PHARMACEUTICALS ADR PLC Health Care Equity 102555.6 2.67
HLUN B H. LUNDBECK CLASS B Health Care Equity 93541.49 2.44
PRTA PROTHENA PLC Health Care Equity 84336.32 2.2
DYN DYNE THERAPEUTICS INC Health Care Equity 81766.5 2.13
EWTX EDGEWISE THERAPEUTICS INC Health Care Equity 77856.6 2.03
SRRK SCHOLAR ROCK HOLDING CORP Health Care Equity 60332.25 1.57
SAVA CASSAVA SCIENCES INC Health Care Equity 57788.6 1.51
BIOA B BIOARCTIC CLASS B Health Care Equity 57270.89 1.49
LBPH LONGBOARD PHARMACEUTICALS INC Health Care Equity 49030.26 1.28
NMRA NEUMORA THERAPEUTICS INC Health Care Equity 42684.85 1.11
WVE WAVE LIFE SCIENCES LTD Health Care Equity 37405.72 0.97
NVRO NEVRO CORP Health Care Equity 36540.28 0.95
ANNX ANNEXON INC Health Care Equity 34824.79 0.91
ALEC ALECTOR INC Health Care Equity 30935.04 0.81
SLDB SOLID BIOSCIENCES INC Health Care Equity 30822.75 0.8
DNTH DIANTHUS THERAPEUTICS INC Health Care Equity 30630.6 0.8
VYGR VOYAGER THERAPEUTICS INC Health Care Equity 29549.96 0.77
AVXL ANAVEX LIFE SCIENCES CORP Health Care Equity 29074.76 0.76
KYTX KYVERNA THERAPEUTICS INC Health Care Equity 28618.57 0.75
PEPG PEPGEN INC Health Care Equity 24897.03 0.65
AXGN AXOGEN INC Health Care Equity 22766.1 0.59
ANRO ALTO NEUROSCIENCE INC Health Care Equity 21948.24 0.57
TRDA ENTRADA THERAPEUTICS INC Health Care Equity 18712.4 0.49
VNDA VANDA PHARMACEUTICALS INC Health Care Equity 15287.7 0.4
CAPR CAPRICOR THERAPEUTICS INC Health Care Equity 13743.1 0.36
2172 MICROPORT NEUROTECH LTD Health Care Equity 13608.48 0.35
LRMR LARIMAR THERAPEUTICS INC Health Care Equity 13563.75 0.35
268600 CELLIVERY THERAPEUTICS INC Health Care Equity 13242.37 0.35
CVRX CVRX INC Health Care Equity 12898.83 0.34
ABEO ABEONA THERAPEUTICS INC Health Care Equity 12367.9 0.32
ABOS ACUMEN PHARMACEUTICALS INC Health Care Equity 12291.8 0.32
AMLX AMYLYX PHARMACEUTICALS INC Health Care Equity 10756.8 0.28
NPCE NEUROPACE INC Health Care Equity 10740.44 0.28
NWRN NEWRON PHARMACEUTICALS Health Care Equity 10275.58 0.27
VTGN VISTAGEN THERAPEUTICS INC Health Care Equity 8020.35 0.21
ATHA ATHIRA PHARMA INC Health Care Equity 6530.56 0.17
BWAY BRAINSWAY ADR REPRESENTING LTD Health Care Equity 6310.5 0.16
USD USD CASH Cash and/or Derivatives Cash 1515.29 0.04
DKK DKK CASH Cash and/or Derivatives Cash 1438.9 0.04
HKD HKD CASH Cash and/or Derivatives Cash 976.56 0.03
SEK SEK CASH Cash and/or Derivatives Cash 920.53 0.02
CHF CHF CASH Cash and/or Derivatives Cash 503.4 0.01
EUR EUR CASH Cash and/or Derivatives Cash 198.03 0.01
KRW KRW CASH Cash and/or Derivatives Cash 184.64 0.0
AUD AUD CASH Cash and/or Derivatives Cash 45.35 0.0
The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See www.iShares.com for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY BEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Bloomberg, BlackRock Index Services, LLC, Cboe Global Indices, LLC, Cohen & Steers, European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Indices, LLC, NSE Indices Ltd, JPMorgan, JPX Group, London Stock Exchange Group (“LSEG”), MSCI Inc., Markit Indices Limited, Morningstar, Inc., Nasdaq, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), Nikkei, Inc., Russell, S&P Dow Jones Indices LLC or STOXX Ltd. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE, LSEG, nor NAREIT makes any warranty regarding the FTSE Nareit Equity REITS Index, FTSE Nareit All Residential Capped Index or FTSE Nareit All Mortgage Capped Index. Neither FTSE, EPRA, LSEG, nor NAREIT makes any warranty regarding the FTSE EPRA Nareit Developed ex-U.S. Index, FTSE EPRA Nareit Developed Green Target Index or FTSE EPRA Nareit Global REITs Index. “FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2023 BlackRock, Inc or its affiliates. All rights reserved. iSHARES, iBONDS and BLACKROCK are trademarks of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners. iCRMH0323U/S-2742939 nan nan nan nan nan